A dose-dependent in exogenous recombinant SRGN protein concentrations was positively correlated with enhanced migratory and metastatic capacities of HCC cells, directly demonstrating SRGN's autocrine-driven role in potentiating tumor cell invasiveness and metastatic progression (Supplementary Figure 4). This evidence concerns the gene SRGN and hepatocellular carcinoma.